disease
Terms related to the query
Term Similarity Weight in brain map N In query
motor
0.003080172486923115
1.0
7928 In expansion
precuneus
0.002160503928595074
0.5311801280651188
5186 In expansion
parietal
0.0012149187628382146
0.5248367497841798
10159 In expansion
temporal
0.001510198187403049
0.33529007000844746
11897 In expansion
occipital
0.0010116596671796978
0.2959387018493348
6796 In expansion
putamen
0.002357372959946432
0.28457678291252675
3208 In expansion
thalamus
0.0007965825259048564
0.2627501070548023
4891 In expansion
cerebellum
0.000680016696972029
0.26216553794184577
5578 In expansion
matter
0.001763927805544694
0.26136281598624456
6324 In expansion
cingulate
0.0008751912335244266
0.25871844098341545
9501 In expansion
hippocampus
0.0006033903312417242
0.21120247807598544
4610 In expansion
dmn
0.0007116160505325622
0.1465718029486179
1351 In expansion
white matter
0.0008204475017257998
0.13622506630257042
4236 In expansion
medial temporal
0.0012407235971671588
0.12150827978651972
2289 In expansion
sma
0.0006107895232581953
0.10996779516684198
2429 In expansion
parahippocampal
0.0005442410620457227
0.10589222547152595
3512 In expansion
frontal
0.0007336166808734826
0.1044654992035867
11471 In expansion
auditory
0.00026785614288966214
0.10427286128709509
4009 In expansion
brainstem
0.000356766956757965
0.10211651717324495
1502 In expansion
caudate
0.0007602595469056304
0.07737388514635049
3615 In expansion
prefrontal
0.00034657439268125377
0.06973362506009405
10017 In expansion
left
0.0006435427022415347
0.0684690908956912
12782 In expansion
white
0.0005378154273543739
0.06834307198014043
6774 In expansion
movement
0.0007373380103179127
0.06158324160923368
8260 In expansion
reho
0.001697736201030327
0.055141331408971754
260 In expansion
dementia
0.008767910320797266
0.0492791541542268
1312 In expansion
right
0.001090645010450694
0.04768403802451155
13076 In expansion
lobe
0.0016070673069557163
0.04407461877604148
7551 In expansion
fusiform
0.0001315371749245323
0.043952829363421465
4278 In expansion
insula
0.00010172177499566803
0.04308612232961487
7050 In expansion
pcc
0.0006146821328364538
0.04008012622965829
1595 In expansion
stimulation
0.0009874658559938811
0.039158964611539546
4565 In expansion
memory
0.0009890547756012701
0.03855769015066106
8405 In expansion
basal ganglia
0.000924892404016571
0.03633953709464795
2555 In expansion
working
0.0003916677306889637
0.034902088685966455
5201 In expansion
motion
0.00012935835718280673
0.03436017049918708
9061 In expansion
premotor
0.0004258493502141904
0.034244049533597526
3200 In expansion
ganglia
0.0008955284427701013
0.03200775697612918
2581 In expansion
olfactory
0.00058100920070144
0.024255043994704115
420 In expansion
orbitofrontal
0.0001927454279656446
0.0237238301245974
3508 In expansion
patient
0.013792253196649914
0.0
7859 In expansion
pathological
0.0021731752195904702
0.0
2628 In expansion
pd
0.04116844346824696
0.0
472 In expansion
parkinson disease
0.036564749131595145
0.0
866 In expansion
parkinson
0.03719124959346712
0.0
967 In expansion
mild
0.0036005953746087193
0.0
1855 In expansion
multiple sclerosis
0.0023514553062537317
0.0
328 In expansion
mci
0.0025830140126118753
0.0
538 In expansion
metabolic
0.006133237702553699
0.0
2051 In expansion
medication
0.0027773254528120853
0.0
3534 In expansion
subthalamic
0.002801733243540449
0.0
256 In expansion
subthalamic nucleus
0.002415334028834567
0.0
216 In expansion
sclerosis
0.0033943977242406943
0.0
512 In expansion
stage
0.002825600224040668
0.0
4722 In expansion
cognitive
0.0029154680564244893
0.0
11288 In expansion
clinical
0.0030672060317657873
0.0
7059 In expansion
carrier
0.0059642874987917835
0.0
503 In expansion
decline
0.002207893010761031
0.0
1831 In expansion
disease
1.0
0.0
5087 In query
control
0.0022435337779743905
0.0
12606 In expansion
alzheimer
0.0413145061603544
0.0
1345 In expansion
alzheimer disease
0.03901397011572272
0.0
1238 In expansion
amyloid
0.0060310573976701575
0.0
245 In expansion
ad
0.040268894856137584
0.0
947 In expansion
alff
0.0023378532280219693
0.0
306 In expansion
biomarker
0.00246179021713012
0.0
957 In expansion
brain
0.0033755925021525597
0.0
13395 In expansion
atrophy
0.007534147436920016
0.0
1332 In expansion
impairment
0.002658971450866994
0.0
5107 In expansion
lewy
0.0026935329788958192
0.0
102 In expansion
emission
0.0029211989117106252
0.0
1987 In expansion
elderly
0.002334416980816466
0.0
790 In expansion
early
0.005389993474949697
0.0
6240 In expansion
dysfunction
0.00296798859048771
0.0
3766 In expansion
frontotemporal
0.0021646717006282997
0.0
953 In expansion
group
0.0036678103486784534
0.0
12268 In expansion
Predicted distribution of activations in the literature
Download map
Publications related to the query
Changes in network activity with the progression of Parkinson’s disease
Parkinson’s Disease and Healthy Aging: Independent and Interacting Effects on Action Selection
Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia
In vivoSPECT imaging of vesicular acetylcholine transporter using [123I]-IBVM in early Alzheimer's disease
CATEGORICAL AND CORRELATIONAL ANALYSES OF BASELINE FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IMAGES FROM THE ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE (ADNI)
A spatial covariance 123I-5IA-85380 SPECT study of α4β2 nicotinic receptors in Alzheimer's disease
Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease
Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease
Patterns of cortical thickness and surface area in early Parkinson's disease
Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease
Pattern of Reduced Functional Connectivity and Structural Abnormalities in Parkinson’s Disease: An Exploratory Study
Residual vectors for Alzheimer disease diagnosis and prognostication
fMRI changes in cortical activation during task performance with the unaffected hand partially reverse after ropinirole treatment in de novo Parkinson's disease
Group comparison of spatiotemporal dynamics of intrinsic networks in Parkinson’s disease
Application of calibrated fMRI in Alzheimer's disease
The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow
Comparison between brain CT and MRI for voxel-based morphometry of Alzheimer's disease
Functional connectivity tracks clinical deterioration in Alzheimer’s disease
Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI
How early can we predict Alzheimer's disease using computational anatomy?
Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease
Network modulation in the treatment of Parkinson's disease
Correlates of movement initiation and velocity in Parkinson’s disease: A longitudinal PET study
ASSOCIATION BETWEEN GAB2 HAPLOTYPE AND HIGHER GLUCOSE METABOLISM IN ALZHEIMER'S DISEASE-AFFECTED BRAIN REGIONS IN COGNITIVELY NORMAL APOEε4 CARRIERS
Abnormal Regional Brain Function in Parkinson’s Disease: Truth or Fiction?
Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project
Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease
Insulin resistance and gray matter volume in neurodegenerative disease
Evaluation of the screening power of Cognitive Abilities Screening Instrument for probable Alzheimer's disease using voxel-based morphometry